Replacing the two Mn 2+ ions normally present in human Arginase I with Co 2+ resulted in a significantly lowered K M value without a concomitant reduction in k cat . In addition, the pH dependence of the reaction was shifted from a pK a of 8.5 to a pK a of 7.5. The combination of these effects lead to a 10-fold increase in overall catalytic activity (k cat /K M ) at pH 7.4, close to the pH of human serum. Just as important for therapeutic applications, Co 2+ substitution lead to significantly increased serum stability of the enzyme. Our data can be explained by direct coordination of L-Arg to one of the Co 2+ ions during reaction, consistent with previously reported model studies. In vitro cytotoxicity experiments verified that the Co 2+ substituted human Arg I displays an approximately 12-15-fold lower IC 50 value for the killing of human hepatocellular carcinoma and melanoma cell lines, and thus constitutes a promising new candidate for the treatment of L-Arg auxotrophic tumors.
Mycoplasma arginii, have been quite effective. Unfortunately, the bacterial origin of ADI results in adverse immune response after repeated administration, a major liability for extended treatment (1) . L-Arg depletion therapy with the human, Mn 2 -dependent enzyme Arginase I (hArgI), has also shown promise for cancer treatment, but has drawbacks that limit its usefulness as a drug candidate.
In contrast to constructing an optimized therapeutic enzyme by the numerous clever protein engineering techniques involving molecular biology used by this lab and others(2-6), we found that thinking about basic chemical principles was invaluable in identifying a derivative of hArgI with increased therapeutic potential. The enzyme hArgI contains a di-nuclear Mn 2+ cofactor in its active site, which is thought to produce a metal-bound hydroxide from water in preparation for attack on the guanidinium carbon of L-Arg. Subsequent hydrolysis gives urea and L-Ornithine (L-Orn) The Mn-hArgI-catalyzed formation of a hydroxide molecule is strongly pH dependent, resulting in an enzyme with an alkaline pH optimum (~9.5)(7) and only fractional activity at physiological pH (~7.4). We reasoned that reducing the pK a of the metalactivated water in hArgI should enhance activity at physiological pH values and result in a more effective therapeutic.
Several lines of evidence suggested that Co 2+ would be a good choice to increase hArgI activity at physiological pH. First, the pK a of the Co 2+ hexaquo-cation (8.9-9.7)(8,9) is known to be about 1 pH unit lower than that of Mn 2+ hexaquo-cation (10.4-10.6)(8-10). Second, bovine carboxypeptidase A with Mn 2+ as a cofactor has an acidic limb kinetic pK a of 6.4, which Co 2+ substitution drops to 5.3 (11) . Similarly the metallo-β-lactamase from B. cereus has a pK a of 8. 4 with Mn 2+ that is depressed to a pK a of 6.9 with Co 2+ as the cofactor (12) . Third, an arginase from H. pylori has been reported that employs Co 2+ as the catalytic metal and displays a relatively acidic pH optimum (13) . Finally, He and Lippard have prepared a series of inorganic arginase model compounds and have shown that complexes of Co 2+ , but not Mn 2+ , Zn 2+ , nor Ni 2+ , could catalyze the hydrolysis of aminoguanindinium (14) . Interestingly, enhanced coordination of the substrate's amino group to the Co 2+ ion, as opposed to a simple shift in pK a of bound water, was presumed to be a major influence on catalytic activity in this case.
Herein we report the construction, biophysical characterization, and chemical effects of Co 2+ substituted hArgI (Co-hArgI). Co-hArgI exhibited the expected decrease in pK a of bound water, but also a substantial decrease in K M of the L-Arg substrate, in the K i for the reaction product L-Orn, as well as in increase in serum stability. The combination of these effects led to an increased cytotoxicity toward hepatocellular carcinoma and melanoma cell lines.
Results and Discussion

Results
Expression and purification of hArgI-The hArgI gene, codon-optimized for expression in E. coli, was constructed using overlapping oligonucleotide assembly. The final construct was fused to an N-terminal His 6 purification tag with a Tobacco Etch Virus (TEV) cleavage site and was expressed from a T7 promoter. High level expression was achieved in E. coli BL21 cells, and following IMAC purification, yielded ~ 200 mg hArgI /L shake flask culture (95 % pure by SDS-PAGE; Figure S1 ).
The effect of Co 2+ on hArgI catalytic activity at physiological pH-As a preliminary check of acticvity using Co 2+ relative to Mn 2+ , E. coli cells expressing hArgI were grown in minimal media and 100 μM MnSO 4 or CoCl 2 was added upon induction of protein synthesis. Addition of the metal inhibited cell growth but did not prevent protein synthesis. The rate of hydrolysis of varying concentrations of L-Arg by clarified cell lysates at pH 7.4 was determined and used to obtain apparent K M values of 1.5 mM and 0.16 mM for Mn 2+ and Co 2+ , respectively. Repeating the experiment in the presence of NiSO 4 or ZnCl 2 lead to apparent K M values of 1.8 mM and 2.0 mM, respectively.
For detailed biochemical analyses, purified hArgI, expressed in the absence of added metal, was incubated at 50 °C for 20 minutes in the presence of either MnSO 4 or CoCl 2 . Following extensive dialysis, the metal content of the protein was analyzed by inductively coupled plasma mass spectroscopy (ICP-MS). Samples of hArgI incubated with CoCl 2 contained 2.1 ± 0.5 equivalents Co 2+ , 0.4 ± 0.1 equivalents Fe 2+ and no Mn 2+ nor Zn 2+ , while samples incubated with MnSO 4 contained 1.5 ± 0.2 equivalents Mn 2+ and 0.4 ± 0.1 equivalents Fe 2+ . As expected, neither Co 2+ nor Zn 2+ were detected in the latter enzyme.
Steady state kinetic analysis in 100 mM Hepes buffer, pH 7.4 at 37 °C revealed that recombinant Mn-hArgI displays a k cat = 300 ± 12 s −1 , K M = 2.3 ± 0.3 mM, and k cat /K M = 129 ± 20 mM −1 s −1 for the hydrolysis of L-Arg. Co-hArgI displayed a 12-fold lower K M equal to 0.19 ± 0.04 mM but a comparable k cat (240 ± 14 s −1 ) resulting in a 10 fold higher k cat /K M = 1,260 ± 330 mM −1 s −1 at physiological pH ( Figure 1 ).
We measured the effect of two competitive inhibitors, product L-Orn and L-Leu at pH 7.4 and pH 8.5 (Table 1) . At pH 7.4 and pH 8.5 the reaction product L-Orn was found to inhibit MnhArgI with a K I = 2.4 ± 0.1 mM and 0.53 ± 0.06 mM respectively, in a comparable range to the value reported for the rat Arginase I at pH 9.0 (K i = 1 mM) (15) . Under the same conditions, Co-hArgI exhibited a K i = 0.076 ± 0.016 mM at pH 7.4 and a K i = 0.064 ± 0.009 at pH 8.5. The inhibition constants for the competitive inhibitor L-Leu were also calculated and found to be of similar magnitude to each other with a K i of 0.48 ± 0.05 mM for Co-hArgI and a K i = 0.39 ± 0.04 mM for Mn-hArgI at pH 7.4. At pH 8.5 L-Leu bound Mn-hArgI with a K i = 0.64 ± 0.04 mM and Co-hArgI with K i = 1.3 ± 0.15 mM, similar to the K i of 1 ± 0.1 reported for hArgII (16) .
pH dependence of Co-hArgI and Mn-hArgI-L-Arg hydrolysis rates by Mn-hArgI are strongly pH dependent with a log k cat slope of 0.5 from pH 6 to pH 8.5. This data can be fit to a one-pK a model (equation 3) with an apparent pK a of 8.1 ± 0.05 in good agreement with previously reported values for hArgII (16) . In contrast, Co-hArgI rates show a greatly shifted pH dependence with a tentative pK a of 5.2 ± 0.1(There is not much data defining this part of the curve, thus is more of an estimate). For the most part the Co-hArgI rate of hydrolysis is mostly pH independent from pH 6 -10.5 (log slope ~ 0.03) (Figure 2A ). Fits to Log plots of 1/K M vs. pH show a bell shaped curve for Mn-hArgI with pK a values of 7.1 ± 0.1and 10.7 ± 0.3, while Co-hArgI has apparent pK a values of 7.2 ± 0.1and 9.7 ± 0.1 ( Figure 2B ). A fit of log k cat /K M vs. pH data to a two pK a Henderson-Hasselbach model (17) resulted in a bell shaped curve with Co-hArgI having an ascending limb pK a of 7.4 ± 0.1 and a descending limb pK a of 10.0 ± 0.1. The data for Mn-hArgI could also fit a bell shaped curve with an ascending limb pK a of 8.4 ± 0.1 and a descending limb with an apparent pK a value of 11.0 ± 0.1 ( Figure 2C ). Because the fitted values are less than 3.5 pH units from each other we applied Segel's method (18) to calculate corrected pK a values of 7.5 and 9.9 for Co-hArgI and values of 8.5 and 10.9 for Mn-hArgI. (It should be noted that there is not much data defining the descending limb pK a of Mn-hArgI and thus is more of an estimate).
X-Ray Absorption Spectroscopy-To examine the metal site structure in more detail, Xray absorption spectra were obtained for Co-hArgI. From the crystal structures of native diMn 2+ enzymes, a six-coordinate metal ion and a five-coordinate metal ion, coordinated by one N from histidine and four or five O donors per metal ion, is anticipated. The EXAFS curve fitting results (see Supplemental Table S1 and Figures S2 ) indicate that the di-Co 2+ active site is less than six-coordinate, with an average of 5 donors (1 His N and 4 O) similar to what was observed in EXAFS study of the rat ArgI di-Mn 2+ enzyme (19) . The apparent heterogeneity of the first shell is due, in large part, to interference from Co 2+ -Co 2+ scattering. While the first coordination sphere appears largely unchanged with respect to the native Mn 2+ enzyme, some rearrangement is indicated, as the metal-metal separation is ~ 0.2 Å longer in the di-Co 2+ enzyme (3.5 ± 0.03 vs. 3.3 Å), which may have an effect on catalysis.
Enzyme Stability-The mid-point temperature (T M ) for unfolding was determined by monitoring the change in the ellipticity at 222 nm (θ 222 ) as a function of T. A fit to the data for Co-hArgI was found to yield a T M = 74 °C (Figure 3) , essentially identical to the T M of 75°C reported earlier for rat Mn-ArgI (20) .
The stability of the enzyme in serum was also evaluated by incubating 1 μM purified enzyme in pooled human serum at 37 °C, while monitoring the rate of hydrolysis of L-Arg as a function of time. Mn-hArgIwas found to display an exponential loss of activity with a t ½ = 4.8 ± 0.8 hrs.
In contrast Co-hArgI exhibited far greater overall serum stability with a bi-phasic loss of activity made up of an apparent first t 1 ½ = 6.1 ± 0.6 hrs and a much slower second phase with a t 2 ½ of 37 ± 3 hrs ( Figure 3 inset)Dissociation of 1 of the 2 metal equivalents in Arginase results in a reduction but not a complete loss in activity (21) and may explain the bi-phasic kinetics of the Co-hArgI enzyme, with one metal rapidly lost and the 2 nd metal being lost much more slowly, corresponding to their respective K D values. This may be species specific as mutagenesis of rat ArgI metal binding residues typically leads to orders of magnitude loss in activity (22) . However, support for this hypothesis was provided by the kinetics of deactivation of Co-hArgI in 100 mM HEPES, pH 7.4, at 37 °C in the presence or absence of 500 μM Co 2+ . In the presence of extra Co 2+ , monophasic sigmoidal loss of activity was observed with a t ½ = 45 ± 2 hrs. 
Cytoxicity towards human cancer cell lines-The
Discussion
Recombinant hArgI was successfully derivatized with Co 2+ as confirmed by ICP-MS analysis, which indicated 2.1 ± 0.5 equivalents Co 2+ per enzyme. EXAFS also revealed the coordination of two Co 2+ ions that have a similar environment, but not identical, to those of the native Mn 2+ ions in the native enzyme. The EXAFS data obtained with Co-hArg1 indicated a Co 2+ -Co 2+ separation of 3.5 ± 0.03 Å, which is 0.2 Å longer than the Mn 2+ -Mn 2+ separation in MnhArgI. It is not clear at this time how these differences might influence the catalytic hydrolysis reaction mechanism, but it is evident that Co 2+ substitution does not drastically alter the active site of hArgI.
Detailed kinetic analyses revealed that consistent with the original experimental design, CohArgI exhibited a pH rate profile for the hydrolysis of L-Arg that appears to represent about a 1 pH unit drop in the pK a of a bound nucleopilic water. In general, the pH dependence of k cat /K M is indicative of ionizations in the free enzyme and the free substrate (E + S). For MnhArgI, the calculated ascending limb pK a of 8.5 most likely reflects the nucleophilic water/ hydroxide equilibrium, although this curve is not well-defined at high pH values. In contrast,
Co-hArgI has a well-defined bell-shaped curve of the pH dependence of k cat /K M with an apparent pK a of 7.5, one pH unit lower than Mn-hArgI. While Co 2+ substitution was expected to depress the pK a of bound water (8) (9) (10) , the full effect may be masked by a change in the rate-limiting step. The pH dependence of k cat for Co-hArgI, which reflects ionizations in the enzyme-substrate complex (ES), shows that except at acidic pH values (5-6), the k cat of CohArgI has almost no global pH dependence (log slope = 0.03), while the Mn-hArgI rate increases more than 30-fold (log slope = 0.5) over the same range , indicating that a rate-limiting step has changed.
In light of the kinetic data, it is reasonable to propose that product release has become ratelimiting for Co-hArgI. Consistent with this notion, the inhibition constant ( A possible mechanism is shown in Scheme 1. L-Arg is proposed to bind in the active site through direct coordination to a Co 2+ ion. In this scenario, the L-Arg is hypothesized to be deprotonated by virtue of a shift in the guanidinium pK a in the vicinity of the strong electrostatic fields of the active site metal ions. Binding of L-Arg as the tautomer shown would facilitate nucleophilic attack by coordinated hydroxide, which in concert with an acidic group to donate a proton, would lead to a tetrahedral intermediate that ultimately collapses to form urea and metal-bound L-Orn. Departure of L-Orn and loss of a proton from bound water might regenerate the resting enzyme with a coordinated hydroxide. An important feature of the proposed mechanism is that a substrate N atom coordinates to the metal ion directly, offering a possible explanation for why the presence of Co 2+ , which is known to have a higher affinity for nitrogen ligands compared to Mn 2+ , exhibits a dramatically lower K M value.
Kostic and coworkers first demonstrated that Pt 2+ terpyridine complexes could coordinate neutral guanidines through an imine nitrogen, (24) something that was thought to be related to the strong acidity of Pt 2+ . However, in a more biologically relevant example, the elegant work of Kimura et al. showed that in a 1:1 Zn 2+ (2-guanidinyl)ethyl-cyclen) complex, the guanidine is a good ligand to Zn 2+ at neutral pH in an aqueous solution. They calculated that the deprotonation of guanidinium in this complex has an apparent pK a of 5.9 (25) . A crystal structure of an arginase from Bacillus caldovex with one of the Mn 2+ ions removed, shows substrate L-Arg coordinated to the remaining metal by a terminal amino nitrogen (PDB:3CEV) (26) . However, the guanidine-metal bond is longer and more distorted than those normally found in small molecule complexes and has not been thought to contribute greatly to substrate binding (27 From a therapeutic standpoint, the lowered K M value and the resulting increase in catalytic efficiency are very important for the overall effectiveness of Co-hArgI relative to Mn-hArgI in cancer cytotoxicity assays. Moreover, Co-hArgI also displayed a significantly enhanced lifetime in human serum compared to Mn-hArgI. Although the origins of this effect are not certain, the fact that both derivatives were found to have similar thermal stabilities may indicate that the reason for the difference in serum stability lies in the properties of the metal ions themselves. Perhaps Co-hArgI is able to retain one or both of its metal ions longer than MnhArgI, an idea supported by retention of catalytic activity observed in the presence of excess Co 2+ ion.
Conclusion
Consistent with the measured k cat /K M values, we found that Co-hArgI exhibits dramatically improved cytotoxicity against human melanoma and hepatocellular carcinoma cell lines relative to the Mn-hArgI. Engineered biological therapeutics have great potential as antineoplastic agents. As opposed to therapeutic antibodies which have stoichiometric interactions, an enzyme therapeutic works as a catalyst and requires far less dosing. There are a number of enzyme based cancer chemotherapies either past or under current clinical evaluation, including: L-asparaginase (Elspar), ribonuclease (Ranpirnase), methionine-γ-lyase, arginine deiminase (Hepacid) and others (29) (30) (31) . In fact, Co-hArgI displayed an IC 50 on par with that of the bacterial ADI which is currently undergoing advanced clinical evaluation. The use of human arginase I variants that display better pharmacological properties represent a major step forward in terms of the ability to treat urea cycle deficient tumors. Co-hArgI is currently undergoing extensive preclinical evaluation in a mouse xenograft model of hepatocellular cancer.
Methods
Construction of Synthetic Genes
Overlapping oligonucleotides (IDT) comprising the coding sequence of a 6 × histidine tag, a Tobacco Etch Virus (TEV) protease recognition site, and human arginase I were combined with dNTPs, buffer and DNA polymerase (Finnzymes) and allowed to react for 30 cycles of 98 °C for 10 s, 70 °C for 20 s, and 72 °C for 1 min. A 1 μL aliquot of this mixture was then used as a template along with specific end primers (Forward '5-GATATACCATGGGTTCTTCTCACCATCATCACCACCACAGCTCTGGCG and Reverse '5-CGAATTCGGATCCTCACTTCGGTGGATTCAGATAATCAATT) in another PCR reaction to amplify the full length gene. The cleaned product (Qiagen) was digested with NcoI and BamHI, ligated into a pET28a vector (Novagen) and transformed into E. coli (DH5α).
Expression and Purification of Arginase
E. coli BL21 cells harboring plasmids containing human arginase were grown in TB media containing 50 μg/ml kanamycin at 37 °C to an OD 600 of ~ 0.5 upon which time IPTG was added to a concentration of 0.5 mM. After an additional ~ 12 hr of incubation at 25 °C, cells were collected by centrifugation re-suspended in IMAC buffer (10 mM NaPO 4 /10 mM imidazole/300 mM NaCl, pH 8) and lysed by a French pressure cell. The lysates were centrifuged at 14,000 × g for 20 min at 4 °C, and the resulting supernatant applied to a cobalt or nickel IMAC column, washed with 10-20 column volumes of IMAC buffer, and then proteins were eluted with IMAC elution buffer (50 mM NaPO 4 / 250 mM imidazole/ 300 mM NaCl, pH 8). Fractions containing enzyme were then incubated with 10 mM metal (CoCl 2 or MnSO 4 ) for 15 min at 50-55 °C, followed by filtration through a 0.45 μm syringe filter. Using a 10,000 MWCO centrifugal filter device (Amicon), proteins were then buffer exchanged several times into a solution comprised of 100 mM HEPES, 10 % glycerol, pH 7.4. Aliquots of purified arginase enzyme were then flash frozen in liquid nitrogen and stored at −80 °C.
Divalent Metal Screening
E.coli cells expressing arginase were grown at 37 °C in minimal media to an OD 600 of 0.8-1. Cells were collected by centrifugation re-suspended in fresh minimal media containing 0.5 mM IPTG, 100 μM of the divalent metal-salt of choice (e.g. CoCl 2 , MnSO 4 , NiCl, ZnCl 2 ), and incubation was continued for an additional 8-12 hours at 25 °C with shaking. Cells were collected by centrifugation and lysed by French pressure cell or by using the B-PER reagent (Pierce). Cleared supernatant was used in activity assays to determine K M values for L-Arg hydrolysis.
Metal Identity and Stoichiometry
In order to determine metal identity content and identity, Mn-hArgI (145 μM), Co-hArgI (182 μM) and associated dialysis buffers were analyzed by inductively coupled plasma mass spectrometry (ICP-MS, Department of Geological Sciences, University of Texas at Austin). The concentration of metal found in dialysis buffer was subtracted from the value obtained in the protein sample and the data were normalized by dividing by the protein concentration. To determine protein concentrations, an extinction coefficient, ε 280 = 24,180 M −1 cm −1 was calculated for hArgI based on amino acid sequence (32) . All protein concentrations were determined from the A 280 in 6 M guanidinium hydrochloride, 20 mM phosphate buffer, pH 6.5. For comparison we also calculated arginase concentration by the BCA assay (Pierce) using dilutions of BSA as a standard and found a similar value.
Kinetic Assays
We used the diacetylmonoxine (DAMO) dervitization of urea in the presence of strong acids, thiosemicarbazide, and Fe 3+ with heating to produce a chromophore with a λ max of ~ 530 nm. The dye structure is not definitively known, but the reaction is hypothesized to be a condensation of DAMO and urea/uriedo that is possibly stabilized by Fe 3+ ions (33) . The assay was shown to be linear between 0 -300 μM urea with a lower detection limit of 1 μM. Typically reactions were performed by equilibrating 1.5 ml Eppendorf tubes containing 200 μL of substrate at 37 °C in a heat block. Reactions were started by adding 5 μL of enzyme solution and quenching with 15 μL of 12 N HCl after 30 sec. Reactions and blanks were then mixed with 800 μL of COLDER (34) and boiled for 15 min. After cooling for 10 min, the samples were transferred to cuvettes and the A 530 nm was determined. Because L-Arg has a background absorbance at A 530 L-Arg blanks were included for all substrate concentrations used.
Product Inhibition of hArgI
Co-hArgI was incubated with 0.25 mM L-Arg in a 100 mM HEPES buffer, pH 7.4, at 37 °C, or with 100 mM Tris buffer pH 8.5 at 37 °C with varying concentrations of L-Orn (0 -1 mM). Mn-hArgI was incubated with 1.5 mM L-Arg in 100 mM Hepes buffer, pH 7.4, at 37 C in the presence of 0-6 mM L-Orn . Mn-hArgI was incubated with 1 mM L-Arg in 100 mM Tris buffer, pH 8.5, at 37 C in the presence of 0-10 mM L-Orn. Data were expressed as percent activity, plotted versus L-Orn concentration and fit to an exponential equation to determine IC 50 values. The K i values were calculated using equation (1), assuming a competitive mechanism(15) and using K M values determined under identical conditions.
(1)
L-Leucine Inhibition of hArgI Co-hArgI was incubated with 0.25 mM L-Arg in a 100 mM HEPES buffer, pH 7.4, at 37 °C with varying concentrations of L-Leucine (L-Leu) (0 -10 mM). Co-hArgI was also incubated with 1 mM L-Arg in a 100 mM Tris buffer, pH 8.5, at 37 °C with varying concentrations of LLeucine (L-Leu) (0 -40 mM). Mn-hArgI was incubated with 1 mM L-Arg in 100 mM Hepes buffer, pH 7.4,or in a 100 mM Tris buffer pH 8.5 at 37 C with varying concentrations of L-Leu (0 -10 mM). Data were expressed as percent activity, plotted versus L-Leu concentration and fit to an exponential equation to determine IC 50 values. The K i values were calculated using equation (1), assuming a competitive mechanism as reported for hArgII (16) and using K M values determined under identical conditions.
pH Rate Dependence of Manganese Arginase, Cobalt Arginase
To examine the pH rate dependence of cobalt and manganese substituted arginase, the steadystate rate constants were determined across a broad range of pH values at 37 °C. The following buffers were used: sodium acetate (pH 5-5.5), MES (pH 6-6.5), HEPES (pH 7-7.8), Tris (pH 8-9), Capso (pH 9-10.5), all at a 100 mM concentration. All enzyme reactions were performed in at least triplicate at 37 °C. Mn 2+ or Co 2+ substituted arginase were each assayed with a range of substrate concentrations from 30 μM to 80 mM, depending on the pH. After fitting the kinetic data to the Michaelis-Menten equation, the k cat /K M values were calculated and plotted versus pH. The resulting bell-shaped data was fit to a form of the Henderson-Hasselbach equation (2) to determine an ascending and descending limb pK a (where y obs = k cat /K M at a given pH, and y max = k cat /K M at the pH optimum). Because fits to two pK a values closer than 3.5 units tend to underestimate y max , Segel's method (equations 4 & 5) was used to calculate corrected pK a values for each limb of the k cat /K M profiles (18) . The pH dependence of k cat showed only one apparent pK a and was fit to equation (3) where y obs is the k cat at a given pH, y max equals the maximum rate and where y min was added to allow for a non-zero plateau at low pH values.
X-Ray Absorption Spectroscopy
Samples of hArgI (~ 1 mM, including 20% (v/v) glycerol added as a glassing agent) were loaded in Lucite cuvettes with 6 μm polypropylene windows and frozen rapidly in liquid nitrogen. X-ray absorption spectra were measured at the National Synchrotron Light Source (NSLS), beamline X3B, with a Si (111) double crystal monochromator; harmonic rejection was accomplished using a Ni focusing mirror. Fluorescence excitation spectra for all samples were measured with a 13-element solid-state Ge detector array. Samples were held at ~ 15 °K in a Displex cryostat during XAS measurements. X-ray energies were calibrated by reference to the absorption spectrum of the appropriate metal foil, measured concurrently with the protein spectra. All of the data shown represent the average of 10 scans per sample. Data collection and reduction were performed according to published procedures (35) 
In Eq. 3, N as is the number of scatterers within a given radius (R as , ± σ as ), A s (k) is the backscattering amplitude of the absorber-scatterer (as) pair, S c is a scale factor, ϕ as (k) is the phase shift experienced by the photoelectron, λ is the photoelectron mean free-path, and the sum is taken over all shells of scattering atoms included in the fit. Theoretical amplitude and phase functions, A s (k)exp(-2R as /λ) and ϕ as (k) , were calculated using FEFF v. 8.00 (38) . The scale factor (S c = 0.74) and ΔE 0 (−26 eV) were determined previously (35) and held fixed throughout this analysis. Fits to the current data were obtained for all reasonable integer or half-integer coordination numbers, refining only R as and σ as 2 for a given shell. Multiple scattering contributions from histidine ligands were approximated according to published procedures, fixing the number of imidazole ligands per metal ion at half-integral values while varying R as and σ as 2 for each of the four combined ms pathways (see Table S1 ) (35) . Co-Co scattering was modeled by fitting calculated amplitude and phase functions to the experimental EXAFS of Co 2 (salpn) 2 .
Circular Dichroism Spectroscopy
A 6 μM sample of Co-hArgI in a 100 mM phosphate buffer, pH 7.4 was analyzed on a Jasco J-815 CD spectrometer. The change in molar ellipticity at 222 nm (θ 222 ) was monitored from 25 - 
Serum Stability of hArgI Variants
Purified Co-hArgI or Mn-hArgI was added to pooled human serum (Innovative, Novi MI) at a concentration of 1 μM and incubated at 37 °C. At various time points, aliquots were withdrawn and tested in triplicate for their ability to hydrolyze L-Arg (1 mM). Data were plotted as observed reaction rate vs. time and fit to either a single exponential equation, or modeled to a biphasic decay model (Equation 6) to calculate T 1/2 values (Where y = v at a given time, y max = v at time 0, y mid = v at end of the first loss of activity, y min = v at the end of the experiment, k is an exponential rate, m is a Hill slope coefficient, T 0.5 = time ½, and τ = time. 
Cytoxicity of Arginase Variants
In order to test the in vitro cytoxicity of arginase, varying concentrations (0 -100 nM) of MnArgI, Co-ArgI, or controls were incubated with HCC (Hep 3b) cells (American Type Culture Collection) or melanoma cells (A373) in 96-well plates at a seeding density of 500 cells/well, in DMEM media supplemented with 10% fetal bovine serum. After 24 hours of incubation at 37 °C, the cells were treated with media containing arginase in triplicate at various concentrations. The treated cells were maintained at 37 °C and 5% CO 2 . Cell viability was determined by the MTT assay (Sigma-Aldrich) on days 1, 3, 5, & 7 by addition of 100 μL/well of MTT (5 mg/mL), followed by incubation for 4 hours, with gentle agitation one to two times per hour. Subsequently, the solution was aspirated, and 200 μL of DMSO was added to each well. Measurements at A 570 nm were determined and the data were normalized relative to the control solution. The resulting data was fit to an exponential equation to determine an apparent IC 50 value.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material. In this proposed mechanism Co-hArgI coordinates a hydroxide molecule. Upon substrate binding L-Arg is deprotonated by Co 2+ and coordinated via an imino guanidine nitrogen. The coordinated hydroxide can then attack the guanidinium carbon and pick up a proton from a general acid. This transient tetrahedral intermediate would then collapse into product urea and L-Orn. Water could then displace L-Orn, and be ionized to hydroxide, regenerating the resting enzyme.
